Contact this trialFirst, we need to learn more about you.
Cytokine
THOR-707 Combination Therapy for Cancer
Recruiting1 awardPhase 1 & 2
Nashville, Tennessee
This trial is testing the safety and effectiveness of a new cancer drug, THOR-707, either alone or in combination with other drugs. The goal is to find the best dose of THOR-707 with the least side effects. Secondary goals are to see if THOR-707 can shrink tumors, and how long any shrinkage lasts.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.